Related stories
J&J Could Pay Ollin’s Backers $2.2 Billion Upfront
Under the deal, J&J could pay Ollin’s backers $2.2 billion upfront in cash, plus $1.2 billion in potential milestone payments.
M impact | MNA | Nov 16, 2026, 12:11 AM UTC
Johnson & Johnson Is Looking to Buy Ollin Biosciences for Up to $3.4 Billion
The Financial Times reported that Johnson & Johnson is looking to acquire Ollin Biosciences for up to $3.4 billion.
M impact | MNA | Nov 16, 2026, 12:11 AM UTC
FT: Johnson & Johnson Looking to Buy Ollin Biosciences for Up to $3.4 Billion
The Financial Times reports that Johnson & Johnson is looking to buy eye-disease biotech Ollin Biosciences for up to $3.4 billion.
M impact | MNA | Nov 16, 2026, 12:01 AM UTC
Adicon Acquisition of Crown Bioscience Will Not Proceed
Adicon's acquisition of Crown Bioscience International will not proceed.
M impact | MNA | Nov 16, 2026, 12:01 AM UTC
Canaccord Genuity Agrees to Go Private Under CEO Dan Daviau
M impact | MNA | Nov 15, 2026, 11:38 PM UTC
Canaccord Genuity Group Agrees to Sell UK Wealth Management Business
Canaccord Genuity Group announced the sale of its wealth management business in the UK and Crown Dependencies to Centerbridge Partners and Mubadala Investment Company.
M impact | MNA | Nov 15, 2026, 11:26 PM UTC